Related Experiment Video
Updated: Jan 18, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
The Influence of Anti-C3aR and Anti-C5aR Antibody Levels on the Course of Specific Glomerulonephritis Types
Maciej Szymczak1, Harald Heidecke2, Marcelina Żabińska3
1Clinical Department of Nephrology, Transplantation Medicine and Internal Diseases Wroclaw Medical University, 50-556 Wroclaw, Poland.
Insights
Autoantibodies against complement receptors C3aR and C5aR are elevated in lupus nephritis patients. These antibody levels correlate with disease markers like albumin and total protein in lupus nephritis and FSGS.
Area of Science:
- Immunology
- Nephrology
Background:
- The complement system's role in autoimmune diseases is established.
- The impact of autoantibodies against complement receptors on glomerular diseases is not well understood.
Purpose of the Study:
- To investigate the levels of anti-C3aR and anti-C5aR antibodies in various glomerular diseases.
- To explore the correlation between these antibodies and clinical outcomes.
Main Methods:
- Measured anti-C3aR and anti-C5aR antibody levels in patients with membranous nephropathy, FSGS, lupus nephritis, IgA nephropathy, mesangial proliferative glomerulonephritis, and ANCA vasculitis.
- Compared antibody levels to a healthy control group.
- Tracked clinical progress (creatinine, total protein, albumin) for up to two years and correlated with antibody levels.
Main Results:
- Lupus nephritis patients exhibited significantly higher anti-C3aR and anti-C5aR antibody levels compared to other groups and healthy controls.
- In lupus nephritis, anti-C3aR levels negatively correlated with albumin and total protein.
- In FSGS, anti-C3aR levels positively correlated with albumin and total protein.
Conclusions:
- Elevated anti-C3aR and anti-C5aR antibodies are characteristic of lupus nephritis.
- These autoantibodies show differential correlations with key clinical markers (albumin, total protein) in lupus nephritis and FSGS, suggesting distinct pathogenic roles.
Abstract:
Background: The complement system factors' role in the pathogenesis of autoimmunological diseases is known, but the influence of autoantibodies against complement factors' receptors on the course of specific glomerular diseases remains unclear. Methods: We measured the levels of anti-C3aR and anti-C5aR antibodies in patients with membranous nephropathy (n = 18), primary focal and segmental glomerulosclerosis (FSGS) (n = 25), lupus nephritis (LN) (n = 17), IgA nephropathy (n = 14), mesangial proliferative (non-IgA) glomerulonephritis (n = 6), c-ANCA (cytoplasmic anti-neutrophil cytoplasmic antibodies) vasculitis (n = 40), and p (perinuclear)-ANCA vasculitis (n = 16). These conditions were compared to a healthy control group (n = 22). Then, for up to two years, we tracked the patients' clinical progress (in terms of creatinine, total protein, and albumin levels) and compared the outcomes with their antibody levels. Results: The lupus nephritis group had higher levels of anti-C3aR and anti-C5aR antibodies than the other groups. The lupus nephritis group's anti-C3aR antibody level showed a negative correlation with albumin and total protein at several time points of observation. Additionally, at numerous observational points, the anti-C3aR antibody level showed a positive correlation with both the basic albumin level in the FSGS group and the total protein level. Conclusions: The anti-C3aR and anti-C5aR antibodies are higher in lupus nephritis patients compared to other glomerulonephritis patients and healthy individuals. Albumin and total protein levels appear to be correlated positively with anti-C3aR antibody levels in FSGS and negatively in lupus nephritis.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Antihypertensive Drugs: Direct Renin Inhibitors